Immunomodulatory effect of human umbilical cord blood derived mesenchymal stem cells on hepatocellular carcinoma cell lines HepG2 /
Hadeer Hesham Abdelfattah Aly
Immunomodulatory effect of human umbilical cord blood derived mesenchymal stem cells on hepatocellular carcinoma cell lines HepG2 / HepG2 التأثير المناعى للخلايا الجذعية الوسيطة المشتقة من دم الحبل السرى البشرى على الخلايا السرطانية للكبد سلالة Hadeer Hesham Abdelfattah Aly ; Supervised Mervat Elsayed Mohamed , Neemat Mohamed Aly Kassem , Mohamed Aly Eldesouky - Cairo : Hadeer Hesham Abdelfattah Aly , 2016 - 123 P. : photographs ; 25cm
Thesis (M.Sc.) - Cairo University - Faculty of Science - Department of Biochemistry
Mesenchymal stem cells (MSCs), one type of adult stem cells, have gained considerable interest as extremely promising cell therapeutic agents due to their unique combination of immunomodulatory properties, self renewal and multilineage differentiation capacity. MSCs are also known for their anti-tumor effect. HCC is the third leading cause of cancer related mortality, responsible for about 600,000 deaths annually. To study the immunomodulatory effect of mesenchymal stem cells on malignant cell lines derived from HCC patients and elucidation of MSCs potential therapeutic effects. This study included MSCs and HepG2 cell lines, MSCs derived from five samples of human umbilical cord blood (UCB) collected immediately after labour from full-term pregnant women with no comorbidities. MSCs derived from UCB have been characterized using monoclonal antibodies (CD34 and CD105) by flow cytometry, then coculture between MSCs and HepG2 cell lines for 7 days with measurement of secreted IL-10 level at days 1, 3 and 7 was conducted. A statistically significant difference regarding IL-10 level was found between day 1 (D1) and day 3(D3) in coculture of MSCs: HepG2 at ratios (1:1, 5:1) with p-value: 0.018 and 0.014 respectively, while not statistically significant at (3:1) ratio and D7. We concluded that the present study showed a possible beneficial effect of hMSCs conditioned media on malignant liver cells via the secretion of IL-10 immunomodulatory cytokine
HCC HepG2 MSCs
Immunomodulatory effect of human umbilical cord blood derived mesenchymal stem cells on hepatocellular carcinoma cell lines HepG2 / HepG2 التأثير المناعى للخلايا الجذعية الوسيطة المشتقة من دم الحبل السرى البشرى على الخلايا السرطانية للكبد سلالة Hadeer Hesham Abdelfattah Aly ; Supervised Mervat Elsayed Mohamed , Neemat Mohamed Aly Kassem , Mohamed Aly Eldesouky - Cairo : Hadeer Hesham Abdelfattah Aly , 2016 - 123 P. : photographs ; 25cm
Thesis (M.Sc.) - Cairo University - Faculty of Science - Department of Biochemistry
Mesenchymal stem cells (MSCs), one type of adult stem cells, have gained considerable interest as extremely promising cell therapeutic agents due to their unique combination of immunomodulatory properties, self renewal and multilineage differentiation capacity. MSCs are also known for their anti-tumor effect. HCC is the third leading cause of cancer related mortality, responsible for about 600,000 deaths annually. To study the immunomodulatory effect of mesenchymal stem cells on malignant cell lines derived from HCC patients and elucidation of MSCs potential therapeutic effects. This study included MSCs and HepG2 cell lines, MSCs derived from five samples of human umbilical cord blood (UCB) collected immediately after labour from full-term pregnant women with no comorbidities. MSCs derived from UCB have been characterized using monoclonal antibodies (CD34 and CD105) by flow cytometry, then coculture between MSCs and HepG2 cell lines for 7 days with measurement of secreted IL-10 level at days 1, 3 and 7 was conducted. A statistically significant difference regarding IL-10 level was found between day 1 (D1) and day 3(D3) in coculture of MSCs: HepG2 at ratios (1:1, 5:1) with p-value: 0.018 and 0.014 respectively, while not statistically significant at (3:1) ratio and D7. We concluded that the present study showed a possible beneficial effect of hMSCs conditioned media on malignant liver cells via the secretion of IL-10 immunomodulatory cytokine
HCC HepG2 MSCs